ArticleBiostatistics (Oxford, England)2019
A Bayesian hidden Potts mixture model for analyzing lung cancer pathology images.
Article in Biostatistics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 26 citations in OpenAlex.
- Deciphering cell to cell spatial relationship for pathology images using SpatialQPFs.Scientific reports · 2024Article
- BACT: nonparametric Bayesian cell typing for single-cell spatial transcriptomics data.Briefings in bioinformatics · 2024Article
- SPARTIN: a Bayesian method for the quantification and characterization of cell type interactions in spatial pathology data.Frontiers in genetics · 2023Article
- A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma.Histopathology · 2022Article
- Lung Cancer Computational Biology and Resources.Cold Spring Harbor perspectives in medicine · 2022Review
- Bayesian hierarchical models for high-dimensional mediation analysis with coordinated selection of correlated mediators.Statistics in medicine · 2021Article
- Spatial molecular profiling: platforms, applications and analysis tools.Briefings in bioinformatics · 2021Review
- Deep Learning Model as a New Trend in Computer-aided Diagnosis of Tumor Pathology for Lung Cancer.Journal of Cancer · 2020Review
- ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network.EBioMedicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
Digital pathology imaging of tumor tissues, which captures histological details in high resolution, is fast becoming a routine clinical procedure. Recent developments in deep-learning methods have enabled the identification, characterization, and classification of individual cells from pathology images analysis at a large scale. This creates new opportunities to study the spatial patterns of and interactions among different types of cells. Reliable statistical approaches to modeling such spatial patterns and interactions can provide insight into tumor progression and shed light on the biological mechanisms of cancer. In this article, we consider the problem of modeling a pathology image with irregular locations of three different types of cells: lymphocyte, stromal, and tumor cells. We propose a novel Bayesian hierarchical model, which incorporates a hidden Potts model to project the irregularly distributed cells to a square lattice and a Markov random field prior model to identify regions in a heterogeneous pathology image. The model allows us to quantify the interactions between different types of cells, some of which are clinically meaningful. We use Markov chain Monte Carlo sampling techniques, combined with a double Metropolis-Hastings algorithm, in order to simulate samples approximately from a distribution with an intractable normalizing constant. The proposed model was applied to the pathology images of $205$ lung cancer patients from the National Lung Screening trial, and the results show that the interaction strength between tumor and stromal cells predicts patient prognosis (P = $0.005$). This statistical methodology provides a new perspective for understanding the role of cell-cell interactions in cancer progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.